Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode

By sjmartinez • December 11, 2024

Pollack CV Jr, Arroyo D, Kanda E, Lázaro IJS, Lesén E, Franzén S, Gray CM, Lipińska A, Murohara T, Rastogi A. Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode. ESC Heart Fail. 2024 Dec 10. doi: 10.1002/ehf2.15171. Epub ahead of print. PMID: 39659133.

Tags: Chronic kidney disease, heart failure, hyperkalaemia, Nephrology, Potassium binder, Publications, renin–angiotensin–aldosterone system inhibitor, sodium zirconium cyclosilicate

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States

Boppana S, Blosser CD, Webber AB, Gupta G, Singh N, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum EL, Khirfan[...]

Prevalence and dynamics of HLA Donor-Specific antibodies in Simultaneous Liver-Kidney transplantation

Zhang Q, Pulido MA, Soltero S, Butler C, Lum E, Abdalla B, Kendrick E, Yabu JM, Pham PT, Bunnapradist S, Veale J, Gritsch AH, Danovitch[...]

Retinal Tear as a Sign of an IgA Nephropathy Flare: A Case Report

Luu Y, Goshtaseb RR. Retinal Tear as a Sign of an IgA Nephropathy Flare: A Case Report. Cureus. 2026 Jan 6;18(1):e100946. doi: 10.7759/cureus.100946. PMID: 41658829;[...]